Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt repayments
Ratios

Avanos Medical (AVNS) Other Gross PP&E Adjustments (2016 - 2026)

Avanos Medical's Other Gross PP&E Adjustments history spans 13 years, with the latest figure at $232.3 million for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 11.1% to $232.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $232.3 million, a 11.1% increase, with the full-year FY2025 number at $232.3 million, up 11.1% from a year prior.
  • Other Gross PP&E Adjustments hit $232.3 million in Q4 2025 for Avanos Medical, down from $235.0 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for AVNS hit a ceiling of $278.1 million in Q1 2023 and a floor of $190.4 million in Q4 2022.
  • Historically, Other Gross PP&E Adjustments has averaged $227.0 million across 5 years, with a median of $226.0 million in 2025.
  • Biggest five-year swings in Other Gross PP&E Adjustments: grew 13.07% in 2021 and later decreased 28.41% in 2024.
  • Tracing AVNS's Other Gross PP&E Adjustments over 5 years: stood at $260.1 million in 2021, then fell by 26.8% to $190.4 million in 2022, then grew by 9.3% to $208.1 million in 2023, then grew by 0.48% to $209.1 million in 2024, then increased by 11.1% to $232.3 million in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for AVNS at $232.3 million in Q4 2025, $235.0 million in Q3 2025, and $219.6 million in Q2 2025.